Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21


Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators; ROCKET AF Steering Committee Investigators.

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.


Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.


The predictive value of plasma biomarkers in discharged heart failure patients: role of troponin I/T.

Perna ER, Címbaro Canella JP, Coronel ML, Macin SM.

Minerva Cardioangiol. 2016 Apr;64(2):165-80. Epub 2015 Nov 23.


Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.

Simpson J, Castagno D, Doughty RN, Poppe KK, Earle N, Squire I, Richards M, Andersson B, Ezekowitz JA, Komajda M, Petrie MC, McAlister FA, Gamble GD, Whalley GA, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC).

Eur J Heart Fail. 2015 Nov;17(11):1182-91. doi: 10.1002/ejhf.346. Epub 2015 Sep 11.


Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure MAGGIC.

Eur Heart J. 2015 May 7;36(18):1106-14. doi: 10.1093/eurheartj/ehu490. Epub 2015 Jan 23. Review.


Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.


Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.


Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.

Poppe KK, Squire IB, Whalley GA, Køber L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN; Meta-Analysis Global Group in Chronic Heart Failure.

Eur J Heart Fail. 2013 Nov;15(11):1220-7. doi: 10.1093/eurjhf/hft101. Epub 2013 Jun 26.


Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study.

Perna ER, Aspromonte N, Cimbaro Canella JP, Di Tano G, Macin SM, Feola M, Coronel ML, Milani L, Parras JI, Milli M, García EH, Valle R.

J Card Fail. 2012 Nov;18(11):822-30. doi: 10.1016/j.cardfail.2012.10.008.


Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.


Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators.

Circ Heart Fail. 2012 May 1;5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242. Epub 2012 Mar 22.


Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis.

Martínez-Sellés M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Køber L, Berry C, Squire I; Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC).

Eur J Heart Fail. 2012 May;14(5):473-9. doi: 10.1093/eurjhf/hfs026. Epub 2012 Mar 8.


Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.


Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.


Increased levels of cardiac troponin-T in outpatients with heart failure and preserved systolic function are related to adverse clinical findings and outcome.

Macin SM, Perna ER, Cimbaro Canella JP, Augier N, Riera Stival JL, Cialzeta J, Pitzus AE, Obregon R, Garcia E, Medina F, Badaracco RJ.

Coron Artery Dis. 2006 Dec;17(8):685-91.


Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.

J Heart Lung Transplant. 2006 Oct;25(10):1230-40.


Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade.

Perna ER, Barbagelata A, Grinfeld L, García Ben M, Címbaro Canella JP, Bayol PA, Sosa Liprandi A.

Am Heart J. 2006 Jan;151(1):84-91.


Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.

Perna ER, Címbaro Canella JP, Macin SM.

Minerva Cardioangiol. 2005 Dec;53(6):523-35. Review.


Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure.

Perna ER, Macín SM, Cimbaro Canella JP, Alvarenga PM, Ríos NG, Pantich R, Augier N, Farías EF, Jantus E, Brizuela M, Medina F.

Int J Cardiol. 2005 Mar 18;99(2):253-61.


High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure.

Perna ER, Macín SM, Cimbaro Canella JP, Alvarenga PM, Pantich RE, Ríos NG, Cialzeta JR, Farías EF, Badaracco JR, Brizuela M, Jantus E, Missov ED.

Med Sci Monit. 2004 Mar;10(3):CR90-5. Epub 2004 Mar 1.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk